Seems like a super important and positive development as it was apparently blocking trial progress in the EU. Also great to see the sites listed as being in four different countries.
Can’t underestimate the importance of getting EU approval. It’s one of the biggest regulatory bodies apart from the US FDA.
Ann: EU Approval for Phase 2 CYP-001 Trial in GvHD, page-3
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $60.17M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 31.5¢ | $22.67K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7864 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.57pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.015 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 33.0¢ | 31.5¢ | 20409 | ||
| Last updated 15.48pm 31/05/2024 ? | |||||
| CYP (ASX) Chart |